← Back to Intel
Insider ActivityELVN
Kunkel Lori Anne, Insider at Enliven Therapeutics, Inc., sold $66K of ELVN
Updated Jun 19, 2026
Kunkel Lori Anne
Insider
Enliven Therapeutics, Inc. ·
$ELVN
Transaction Details
| Insider | Kunkel Lori Anne |
|---|---|
| Title | Insider |
| Company | Enliven Therapeutics, Inc. |
| Ticker | ELVN |
| Transaction Type | Sale |
| Transaction Date | 2026-06-05 |
| Shares Traded | 1,867 |
| Price Per Share | $35.3573 |
| Total Value | $66K |
| Filed Date | 2026-06-09 |
| Accession Number | 0001536368-26-000004 |
Ownership Context
| Shares Owned After Transaction | 52,238 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001536368-26-000004
Other Insider Trades — ELVN
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner | sold | $12.3M | 2026-06-15 |
| ORBIMED ADVISORS LLC | 10% Owner | sold | $409K | 2026-06-15 |
| Kunkel Lori Anne | Insider | sold | $267K | 2026-06-05 |
| Kunkel Lori Anne | Insider | sold | $13K | 2026-06-05 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $137K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | traded | $12K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $52K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $9K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | traded | $12K | 2026-04-17 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $115K | 2026-04-17 |
Other Trades by Kunkel Lori Anne
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | sold | $267K | 2026-06-05 |
| ELVN | Enliven Therapeutics, Inc. | sold | $13K | 2026-06-05 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ELVN — Enliven Therapeutics, Inc. →
Whisper Score — ELVN
50.0
Active Discussion
Current Whisper Score
Track ELVN insider activity in real time on The Wire →
Get alerts when Kunkel Lori Anne files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 19, 2026 at 07:03 UTC